...
机译:创伤性增殖性玻璃体病疗法临床和组织病理学观察
Peking Univ Hosp 3 Key Lab Vis Loss &
Restorat Dept Ophthalmol Minist Educ Beijing Peoples R;
Peking Univ Hosp 3 Key Lab Vis Loss &
Restorat Dept Ophthalmol Minist Educ Beijing Peoples R;
Peking Univ Hosp 3 Key Lab Vis Loss &
Restorat Dept Ophthalmol Minist Educ Beijing Peoples R;
Beijing Tsinghua Changgung Hosp Dept Ophthalmol Beijing Peoples R China;
Peking Univ Hosp 3 Key Lab Vis Loss &
Restorat Dept Ophthalmol Minist Educ Beijing Peoples R;
Peking Univ Hosp 3 Key Lab Vis Loss &
Restorat Dept Ophthalmol Minist Educ Beijing Peoples R;
open globe injury; proliferative vitreoretinopathy; traction retinal detachment; vitrectomy;
机译:创伤性增殖性玻璃体病疗法临床和组织病理学观察
机译:兔眼中实验增殖性玻璃体术治疗鼻咽癌的组织病理学和眼科评价
机译:使用Dasatinib的持续释放系统预防创伤后性增殖性玻璃体病变
机译:血管内低水平激光辐照治疗对创伤性疼痛治疗的临床观察:149例治疗病例报告
机译:小儿创伤后应激障碍的静息状态fMRI研究:预处理优化和临床观察。
机译:依那西普对创伤后增生性玻璃体视网膜病变的影响
机译:玻璃体内可生物降解的缓释萘普生和5-氟尿嘧啶系统,用于治疗实验性创伤后增生性玻璃体视网膜病变
机译:严重Vogt-Koyanagi-Harada综合征的临床和组织病理学观察。